Licox

Integra LifeSciences is a global leader in medical technology, specializing in neurosurgical solutions and regenerative medicine. The company's Licox® Brain Tissue Oxygen Monitoring System is the most widely studied and documented platform for continuous, real-time monitoring of brain tissue oxygen partial pressure (PtO2) and temperature. This technology is critical in neurocritical care settings for managing patients with traumatic brain injury (TBI) or cerebral vascular events, as it provides early warning of hypoxic events that could lead to secondary brain damage. Originally developed by GMS mbH and acquired by Integra in 2001, the Licox system is a key component of Integra's multimodal monitoring portfolio, which also includes the Camino® intracranial pressure (ICP) monitoring system. Headquartered in Princeton, New Jersey, Integra is publicly traded on NASDAQ under the symbol IART and serves healthcare providers worldwide.